Press Release Archive
-
Johnson & Johnson Reports 2018 First-Quarter Results
-
Janssen Announces Worldwide Development and Commercialization Collaboration with Bristol-Myers Squibb to Advance a Next-Generation Therapy for Cardiovascular Diseases
-
Newly Published Phase 2 Study Found Esketamine Demonstrated Significantly Rapid Improvements in Depressive Symptoms and Suicidality
-
INVOKANA® (canagliflozin) Demonstrated Significant Renal Protective Benefits in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
-
Johnson & Johnson Vision Announces Revolutionary Contact Lens Innovation with ACUVUE OASYS® with Transitions® Light Intelligent Technology™
-
Johnson & Johnson Institute Adds Innovative Analytics-Based Learning Platform to Help Surgeons Improve Technical Skills and Clinical Outcomes Across a Range of SpecialtiesUse of digital technology and analytics will reinvent professional education
-
Ethicon Highlights New Capabilities to Reduce Exposure to Surgical Smoke at the Association of PeriOperative Nurses (AORN) Conference
-
Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & JohnsonJoseph Wolk Promoted to Executive Vice President, Chief Financial Officer
-
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
-
Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.